Recent Discovery of Peptidomimetics for the Treatment of Coronavirus (COVID-19), Human Coronavirus, and Enteroviruses-Reference-Cited by-同舟云学术

Recent Discovery of Peptidomimetics for the Treatment of Coronavirus (COVID-19), Human Coronavirus, and Enteroviruses

Published:2024-03 Issue:10 Volume:31 Page:1289-1295
ISSN:0929-8673
Container-title:Current Medicinal Chemistry
language:en
Short-container-title:CMC

Author:

De Surya K.¹²

Affiliation:

1. Department of Chemistry, Conju-Probe, San Diego, California, USA

2. Bharath University, Chennai, Tamil Nadu, 600126, India

Abstract

Abstract: This patent describes the synthesis of compounds, methods, and compositions for preventing, treating, and/or curing Covid-19, human coronavirus, and enterovirus infections. Some peptidomimetic compounds are very potent and could be a game changer in new treatment therapy for COVID-19.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry

Reference21 articles.

1. Alfarouk K.O.; AlHoufie S.T.S.; Ahmed S.B.M.; Shabana M.; Ahmed A.; Alqahtani S.S.; Alqahtani A.S.; Alqahtani A.M.; Ramadan A.M.; Ahmed M.E.; Ali H.S.; Bashir A.; Devesa J.; Cardone R.A.; Ibrahim M.E.; Schwartz L.; Reshkin S.J.; Pathogenesis and management of COVID-19. J Xenobiot 2021,11(2),77-93

2. Mackie P.L.; The classification of viruses infecting the respiratory tract. Paediatr Respir Rev 2003,4(2),84-90

3. Peters C.E.; Schulze-Gahmen U.; Eckhardt M.; Jang G.M.; Xu J.; Pulido E.H.; Bardine C.; Craik C.S.; Ott M.; Gozani O.; Verba K.A.; Hüttenhain R.; Carette J.E.; Krogan N.J.; Structure-function analysis of enterovirus protease 2A in complex with its essential host factor SETD3. Nat Commun 2022,13(1),5282

4. Bagwe P.V.; Bagwe P.V.; Ponugoti S.S.; Joshi S.V.; Peptide-based vaccines and therapeutics for COVID-19. Int J Pept Res Ther 2022,28(3),94

5. Zhu J.; Zhang H.; Lin Q.; Lyu J.; Lu L.; Chen H.; Zhang X.; Zhang Y.; Chen K.; Progress on SARS-CoV-2 3CLpro inhibitors: Inspiration from SARS-CoV 3CLpro peptidomimetics and small-molecule anti-inflammatory compounds. Drug Des Devel Ther 2022,16,1067-1082